Medicare Enrolled

Dr. Francisco Fantauzzi-Nazario, M.D.

Emergency Medicine · Savannah, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
11909-D MCAULEY DRIVE, Savannah, GA 31419
9129270785
In practice since 2006 (19 years)
NPI: 1821161688 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fantauzzi-Nazario from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fantauzzi-Nazario? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fantauzzi-Nazario

Dr. Francisco Fantauzzi-Nazario is an emergency medicine specialist in Savannah, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fantauzzi-Nazario performed 825 Medicare services across 497 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fantauzzi-Nazario received a total of $7,447 from 49 pharmaceutical and/or device companies across 441 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in emergency medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fantauzzi-Nazario is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 10% volume in GA $7,447 industry payments

Medicare Practice Summary

Medicare Utilization ↗
825
Medicare services
Top 10% in GA for emergency medicine
497
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
377 $58 $182
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
249 $69 $267
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
112 $10 $30
Drug test with direct observation
A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process.
39 $12 $35
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
13 $29 $61
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
12 $8 $14
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
12 $114 $277
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
11 $72 $175
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,447
Total received (2018-2024)
Avg $1,064/year across 7 years
Top 2% in GA for emergency medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
441
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,447 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,689
2023
$2,044
2022
$2,213
2021
$1,180
2020
$167
2019
$107
2018
$48

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$332
AstraZeneca Pharmaceuticals LP
$263
Novo Nordisk Inc
$250
Lilly USA, LLC
$195
GlaxoSmithKline, LLC.
$85
Amgen Inc.
$75
Phathom Pharmaceuticals, Inc.
$64
IDORSIA PHARMACEUTICALS US INC
$51
Novartis Pharmaceuticals Corporation
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
Paratek Pharmaceuticals, Inc.
$37
PFIZER INC.
$36
Sumitomo Pharma America, Inc.
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
Astellas Pharma US Inc
$28
Merck Sharp & Dohme LLC
$25
Abbott Laboratories
$24
Boston Scientific Corporation
$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$20
Lundbeck LLC
$18
Bayer Healthcare Pharmaceuticals Inc.
$14
Top 3 companies account for 50.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,148
ABBVIE INC.
$773
Lilly USA, LLC
$763
Amgen Inc.
$637
AstraZeneca Pharmaceuticals LP
$457
PFIZER INC.
$373
Boehringer Ingelheim Pharmaceuticals, Inc.
$274
Bayer Healthcare Pharmaceuticals Inc.
$241
Novartis Pharmaceuticals Corporation
$237
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$207
SANOFI-AVENTIS U.S. LLC
$186
Otsuka America Pharmaceutical, Inc.
$180
GlaxoSmithKline, LLC.
$156
Dexcom, Inc.
$138
Bayer HealthCare Pharmaceuticals Inc.
$109
Boston Scientific Corporation
$106
Daiichi Sankyo Inc.
$93
Biohaven Pharmaceuticals, Inc.
$92
AbbVie Inc.
$91
IDORSIA PHARMACEUTICALS US INC
$86
Merck Sharp & Dohme LLC
$86
Exact Sciences Corporation
$79
Biohaven Pharmaceutical Holding Company Ltd.
$70
Kowa Pharmaceuticals America, Inc.
$68
Astellas Pharma US Inc
$65
Phathom Pharmaceuticals, Inc.
$64
DEXCOM, INC.
$63
Xeris Pharmaceuticals, Inc.
$59
Amarin Pharma Inc.
$57
Avanir Pharmaceuticals, Inc.
$49
Merck Sharp & Dohme Corporation
$40
Genentech USA, Inc.
$40
Paratek Pharmaceuticals, Inc.
$37
Eisai Inc.
$34
Sumitomo Pharma America, Inc.
$33
Mission Pharmacal Company
$30
Abbott Laboratories
$24
Shield Therapeutics Inc
$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$20
Hikma Pharmaceuticals USA
$19
Eyevance Pharmaceuticals LLC
$19
SANOFI PASTEUR INC.
$18
Lundbeck LLC
$18
Alexion Pharmaceuticals, Inc.
$17
Esperion Therapeutics, Inc.
$16
EISAI INC.
$15
Janssen Pharmaceuticals, Inc
$13
Apria Healthcare LLC
$13
Allergan Inc.
$12
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · Aduhelm · Aimovig · BELSOMRA · BREZTRI · CAPLYTA · CHANTIX · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DIFICID · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · GEMTESA · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · GVOKE PFS · INJECTAFER · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · Livalo · MOUNJARO · Medela · Mitigare · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · Nuedexta · Otezla · Ozempic · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prednisolone 25 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · STRENSIQ · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tobradex ST · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for emergency medicine in GA.

Looking for an emergency medicine specialist in Savannah?
Compare emergency medicines in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse emergency medicines nearby

Geographic Context

Emergency medicines within 10 mi
101
Per 100K population
33.9
County median income
$69,575
Nearest hospital
ST JOSEPH'S HOSPITAL - SAVANNAH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Fantauzzi-Nazario is a clinical cardiology specialist, with above-average Medicare volume (top 10% in GA), with low-engagement industry engagement in the top 2% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Fantauzzi-Nazario experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Fantauzzi-Nazario performed 377 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fantauzzi-Nazario receive payments from pharmaceutical companies?
Yes. Dr. Fantauzzi-Nazario received a total of $7,447 from 49 companies across 441 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fantauzzi-Nazario's costs compare to other emergency medicines in Savannah?
Dr. Fantauzzi-Nazario's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fantauzzi-Nazario) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →